心怡康口服液治疗病毒性心肌炎92例临床观察

目的 观察中成药心怡康口服液治疗病毒性心肌炎（属于中医气阴两虚、邪毒侵心型）的临床疗效。方法 采用随机加扩大对照法，治疗组９２例使用心怡康口服液治疗；对照组３０例使用芪冬颐心口服液治疗。疗程均为４周。观察两组治疗前后症状、体征及白细胞（ＷＢＣ）、血沉（ＥＳＲ）、谷草转氨酶（ＡＳＴ）、乳酸脱氢酶（ＬＤＨ）、肌酸磷酸激酶（ＣＰＫ）及其同功酶（ＣＰＫ－ＭＢ）、心电图、动态心电图的变化。结果 治疗组对改善

Clinical Observation on Therapeutic Effect of Xinyikang Oral Liquid in Treating 92 Patients of Viral Myocarditis

Objective: To observe the clinical effect of Xinyikang Oral Liquid (XYK) in treating viral myocarditis patients of Qi Yin Deficiency and Evil Toxin Encroaching Heart Type. Methods: Randomized controlled method was adopted, the 92 cases in the XYK group received XYK and 30 cases in the control group received Qidong Yixin oral liquid treatment for 4 weeks as a therapeutic course. Their symptoms, signs, white blood cell count (WBC), erythrocyte sedimentation rate (ESR), lactate, aspartate aminotransferase (AST) dehydrogenase (LDH), creatine phosphokinase (CPK), creatine phosphokinase isoenzyme (CPK MB), electrocardiogram (ECG) and dynamic ECG changes before and after treatment were observed. Results: The improvement on chest stuffiness, short breath, fatigue and spontaneous perspiration in the treatment group was better than those in the control group (P<0 05) and XYK showed obvious improving effect on ESR, AST, LDH, CPK and CPK MB (P<0 01 or 0.05). There was no adverse reaction or side toxic effects revealed in using XYK. Conclusion: XYK has significant therapeutic effect in treating viral myocarditis.